A clinical trial to study the safety and efficacy of NRC-AN-019 in patients with chronic Myeloid Leukemia who are not responding or intolerant to Imatinib mesylate

Category Primary study
Registry of TrialsClinical Trials Registry - India
Year 2009
This article has no abstract
Epistemonikos ID: 7c658e16fda501f57d3d99dc26a2343a906a015c
First added on: Apr 16, 2025